Orthonotes Logo
Orthonotes
by the.bonestories

Nonunion — Weber & Cech Classification

10 Views

Category: Trauma

Share Wiki QR Card Download Slides (.pptx)
Viable (hypertrophic/oligotrophic) vs non‑viable (atrophic, necrotic, defect, comminuted). Radiographic callus indicates biology; absence suggests poor biology. Guides treatment: stability alone for viable; add graft/biologics for non‑viable. viable → improve stability; nonviable → improve stability + add biology.
Published Feb 28, 2026 • Author: The Bone Stories ✅
🧠 Test Yourself with OrthoMind AI

10 AI-generated high-yield questions by our AI engine



Overview & Definition

Nonunion is defined as the failure of a fracture to unite within the expected timeframe for that fracture, with radiological and clinical evidence that further healing will not occur without intervention. While delayed union implies that healing is proceeding but more slowly than expected, nonunion indicates that the biological healing process has ceased. The distinction is not merely academic — the underlying biology of the nonunion determines the appropriate treatment. The Weber and Cech classification remains the most clinically useful system because it directly classifies nonunions by their biological activity, guiding whether mechanical stabilisation alone, biological stimulation, or both are required.

  • Definition of nonunion: the US FDA definition — fracture that has not healed after 9 months from injury and has shown no progressive signs of healing on serial radiographs for 3 consecutive months; in clinical practice, the definition is adapted to the fracture and patient — some fractures (tibial shaft, femoral neck) are expected to unite earlier; the `9-month` threshold is a regulatory definition, not an absolute clinical rule; clinical and radiological context determines when a fracture has genuinely arrested healing
  • Causes of nonunion: the `diamond concept` (Giannoudis et al.) identifies four elements required for fracture healing: (1) osteogenic cells (mesenchymal stem cells); (2) osteoinductive growth factors (BMPs, TGF-β, IGF); (3) osteoconductive scaffold (extracellular matrix); (4) mechanical stability; failure of ANY of these elements causes nonunion; additional systemic factors: diabetes (impaired cellular migration and angiogenesis), smoking (vasoconstriction, impaired oxygen delivery — the single most modifiable risk factor), NSAID use (COX-2 inhibition impairs prostaglandin-mediated osteoblast recruitment), hypothyroidism, malnutrition, osteoporosis, infection, open fractures (periosteal stripping), high-energy injury, distraction at the fracture site
Weber & Cech Classification

The Weber and Cech classification (1976) divides nonunions into two major groups based on their biological viability — the presence or absence of vascularity and biological activity at the fracture ends. This directly determines the treatment strategy.

Type Subtype Biology X-Ray Appearance Cause Treatment Principle
Viable (Vascular) — `Reactive` Hypertrophic (`Elephant foot`) Excellent vascularity; active osteoblasts; abundant callus; the biology is adequate — the problem is mechanical instability preventing callus maturation Abundant exuberant callus at both fracture ends (`elephant foot` shape); callus is large and bulbous; fracture line still visible through the callus Inadequate mechanical stability (e.g., cast that has cracked, nails that have dynamised too early, intramedullary nail that is too thin or unlocked too early) Stabilisation alone is sufficient — the biological environment is excellent; rigid internal fixation (exchange nailing, compression plating) will lead to union without bone grafting; the callus will mature once stability is provided
Moderately hypertrophic (`Horse hoof`) Good vascularity; moderate callus; adequate biology but slightly less active than elephant foot Moderate callus with a `horse-hoof` pattern; smaller callus than elephant foot Moderate instability; partially effective fixation Stabilisation ± bone graft; if biology is borderline, addition of autograft or bone graft substitute is prudent
Oligotrophic Some vascularity; minimal callus; the fracture ends are viable but not actively forming callus; the biology is present but not stimulated (often because the fragments are distracted or not in contact) Very little or no visible callus; fracture ends are visible but not sclerotic; gap between the ends; fragments are not in contact Fragment distraction; fibrous interposition; inadequate reduction (gap too large for callus to bridge) Stabilisation + reduction to bring fragments into contact + bone graft; the lack of contact between viable ends explains the minimal callus; once contact is restored and stability provided, bone graft stimulates union
Non-viable (Avascular) — `Areactive` Torsion wedge Intermediate fragment (torsion or butterfly fragment) is avascular; has lost its blood supply; the main fragments are viable but the intermediate fragment is dead An intermediate fragment with no callus; the main fragments may have some callus but the dead intermediate fragment does not Comminuted fracture with displacement; the intermediate fragment`s periosteal blood supply is stripped Stabilisation + bone graft (to replace or revascularise the avascular fragment); the dead fragment may need to be excised and replaced with graft, or the nonunion compressed across it
Comminuted Multiple devascularised fragments; none of the fragments have adequate blood supply; the fracture zone is a biologically dead field Multiple fragments with no callus; sclerotic, avascular-appearing fragments; no biological activity visible High-energy comminuted fracture; extensive periosteal stripping; open fracture Stabilisation + aggressive bone grafting (iliac crest autograft is the gold standard); the avascular zone must be debrided to bleeding bone and packed with autograft; or Masquelet technique (induced membrane) for large avascular segments
Defect / Atrophic True bone defect — one or both fracture ends have undergone resorption; the bone ends are `pencil-shaped`, tapered, and avascular; no callus; no biological activity; this is the worst biological scenario `Pencil-point` or `cigar-end` tapering of the fracture ends; no callus; sclerotic bone; gap between the ends (defect); the medullary canal is sealed at the atrophic end Long-standing nonunion; repeated failed surgeries; infection; poor vascularity; systemic factors (smoking, diabetes) Most demanding treatment: stabilisation + aggressive debridement of atrophic ends to bleeding bone + large volume bone graft (iliac crest autograft, bone transport via Ilizarov/Taylor Spatial Frame, Masquelet induced membrane technique for defects >2 cm); both stability AND biology must be restored from scratch
Treatment Strategies
  • Exchange nailing: the most effective treatment for hypertrophic/oligotrophic tibial and femoral nonunions after prior intramedullary nail fixation; the original nail is removed; the medullary canal is reamed to a larger diameter (reaming stimulates endosteal vascularity, releases osteogenic cells and BMPs from the reamed cortical debris, and allows insertion of a larger, stiffer nail); a larger diameter nail is inserted (restoring torsional and bending stiffness); union rates of 70–90% for tibial shaft nonunions after exchange nailing; particularly effective for hypertrophic nonunions where biology is adequate but mechanical stability is insufficient
  • Compression plating: for nonunions not previously treated with IM nailing, or where exchange nailing has failed; rigid compression plate applied after debridement of the nonunion site; the fracture ends are freshened to bleeding bone; interfragmentary compression is applied; ± autologous bone graft packed at the nonunion site; particularly used for periarticular nonunions (femoral neck — blade plate; tibial plateau; distal humerus) not amenable to IM nailing
  • Masquelet technique (induced membrane technique): a two-stage procedure for large bone defects and atrophic nonunions; Stage 1 — radical debridement of the nonunion site, temporary cement spacer (PMMA/antibiotic-loaded) inserted into the defect; the cement induces formation of a biological `induced membrane` (rich in growth factors — VEGF, BMP-2, TGF-β1) around it over 6–8 weeks; Stage 2 — spacer removed; the induced membrane is opened; the cavity is packed densely with autologous cancellous bone graft (iliac crest) or bone substitute; the membrane is closed over the graft; the growth-factor-rich membrane vascularises and incorporates the graft; highly effective for defects of 2–10 cm that would otherwise require bone transport; avoids the prolonged treatment with Ilizarov frames
  • Ilizarov / bone transport: for large bone defects (>5–6 cm) or atrophic nonunions where the Masquelet technique is not feasible; the Ilizarov circular external fixator (or modern equivalent — Taylor Spatial Frame) is applied; a corticotomy is performed proximally to create a regenerate zone; the bone segment is slowly transported (1 mm/day in 0.25 mm increments, 4 times daily) to fill the defect while new bone (regenerate) forms at the corticotomy site; technically demanding; prolonged treatment duration (months to years); pin-site infections; but achieves union with restoration of limb length in cases where no other technique would succeed
  • Bone grafting options: (1) Iliac crest autograft — gold standard for biological stimulation; provides osteogenic cells (MSCs), osteoinductive factors (BMPs), and osteoconductive scaffold; donor site morbidity (10–30% chronic pain); (2) Reamer-irrigator-aspirator (RIA) graft — aspirates autologous bone graft from the medullary canal of the femur or tibia using a powered reaming system; large volume of graft harvested (30–90 mL) with low donor site morbidity compared to iliac crest; increasingly preferred for large defects; (3) Bone morphogenetic proteins (BMP-2, BMP-7/OP-1) — potent osteoinductive cytokines; BMP-7 (Osigraft) approved for tibial nonunion in UK; BMP-2 (Infuse) approved for certain applications; expensive; associated with heterotopic ossification and oedema; (4) Demineralised bone matrix (DBM) — processed allograft; retains osteoinductive properties; used as graft extender; (5) Calcium phosphate/calcium sulphate — osteoconductive only; used as scaffold extender; no osteogenic or osteoinductive activity
Exam Pearls
  • Weber & Cech: viable (reactive) = elephant foot (hypertrophic — abundant callus, mechanically unstable → stabilise only), horse hoof (moderate callus → stabilise ± graft), oligotrophic (minimal callus, gap → stabilise + bring into contact + graft); non-viable (areactive) = torsion wedge, comminuted, atrophic → stabilise + aggressive bone grafting mandatory
  • Key principle: hypertrophic nonunion = mechanical problem → stabilisation alone is curative (biology is intact); atrophic nonunion = biological problem → both stability and biology must be restored (bone graft is mandatory)
  • Elephant foot diagnosis: exuberant callus on both ends; fracture line still visible through the callus; cause = inadequate stability despite good biology; treatment = exchange nail or compression plate (no graft needed); union rates very high
  • Diamond concept: osteogenic cells + osteoinductive factors + osteoconductive scaffold + mechanical stability = all four required for fracture healing; nonunion = failure of one or more; treatment must restore the deficient elements
  • Exchange nailing: treatment of choice for hypertrophic/oligotrophic tibial nonunion after prior IM nail; reaming releases BMPs and osteogenic cells + larger stiffer nail; union rate 70–90%; most effective single treatment for tibial shaft nonunion
  • Masquelet technique: two-stage; cement spacer induces membrane rich in growth factors (VEGF, BMP-2, TGF-β); Stage 2 = spacer removed + dense autograft packed into the membrane envelope; for defects 2–10 cm; avoids prolonged Ilizarov treatment
  • RIA graft: reamer-irrigator-aspirator from femur/tibia medullary canal; large volume (30–90 mL); lower donor site morbidity than iliac crest; gold standard volume for large defect grafting
  • Modifiable risk factors for nonunion: smoking (most important — cessation mandatory before elective nonunion surgery); NSAIDs (stop perioperatively); diabetes (optimise HbA1c <7.5%); hypothyroidism (treat); malnutrition (vitamin D, zinc, protein supplementation); infection (eradicate before grafting)
  • BMP-7 (Osigraft): approved in UK for tibial nonunion as alternative to autologous iliac crest graft; osteoinductive; risk of heterotopic ossification; expensive; not first-line
🧠 Test Yourself with OrthoMind AI

10 AI-generated high-yield questions by our AI engine

References

Weber BG, Cech O. Pseudarthrosis — Pathophysiology, Biomechanics, Therapy, Results. Grune & Stratton. 1976.
Giannoudis PV, Einhorn TA, Marsh D. Fracture healing — the diamond concept. Injury. 2007;38(Suppl 4):S3–6.
Brinker MR, O`Connor DP. Exchange nailing of ununited fractures. J Bone Joint Surg Am. 2007.
Masquelet AC, Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am. 2010.
Ilizarov GA. Clinical application of the tension-stress effect for limb lengthening. Clin Orthop Relat Res. 1990.
Govender S et al. Recombinant human BMP-2 for treatment of open tibial fractures (BESTT study). J Bone Joint Surg Am. 2002.
Dimitriou R et al. Current concepts of molecular aspects of bone healing. Injury. 2005.
Kuhns CA, Rueger JM. Bone graft substitutes in trauma and reconstructive surgery. Orthopedics. 2009.
Campbells Operative Orthopaedics. 14th Edition. Elsevier.
Orthobullets — Nonunion; Weber Cech Classification; Bone Grafting; Masquelet Technique; Exchange Nailing.